Ruth Yakar, Founder of BioSight

Ruth Yakar is the founder of BioSight. BioSight has raised $59M in total funding. Latest round: Series C. Based in Airport City, Israel.

About Ruth Yakar

Ruth Ben Yakar (also known as Ruth Yakar) is the CEO of BioSight Ltd., an Israel-based clinical-stage biotech company developing therapeutics for hematological malignancies. She leads the company's development of Astrabine (aspacytarabine/BST-236), a drug designed to kill cancer cells while sparing normal cells.

Ruth Yakar at a glance

More founders in Airport City, Israel (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library